How I treat refractory acute GVHD.

@article{Deeg2007HowIT,
  title={How I treat refractory acute GVHD.},
  author={H Joachim Deeg},
  journal={Blood},
  year={2007},
  volume={109 10},
  pages={4119-26}
}
Graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation (HCT) is associated with considerable morbidity and mortality, particularly in patients who do not respond to primary therapy, which usually consists of glucocorticoids (steroids). Approaches to therapy of acute GVHD refractory to "standard" doses of steroids have ranged… CONTINUE READING